{"id":727191,"date":"2023-01-31T08:48:36","date_gmt":"2023-01-31T13:48:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\/"},"modified":"2023-01-31T08:48:36","modified_gmt":"2023-01-31T13:48:36","slug":"standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\/","title":{"rendered":"Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results"},"content":{"rendered":"
\n

SOUTH SAN FRANCISCO, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose \u2013\u202fUnleashing tools to accelerate breakthroughs in human health<\/em> \u2013 today announced that it will report fourth quarter and full year 2022 financial results on\u00a0Tuesday, February 14, 2023, after the close of the market.<\/p>\n

The Company\u2019s management will host a conference call and webcast at\u00a02:00 p.m. PT, 5:00 p.m. ET, on February 14, 2023, to discuss fourth quarter and full year 2022 financial results and operational progress. A press release outlining the financial results will be publicly distributed before the call.<\/p>\n

Individuals interested in listening to the conference call may do so by dialing:<\/p>\n

US domestic callers: (888) 346-3970
Outside US callers: (412) 902-4297<\/p>\n

Live audio of the webcast will be available online on the Investor Relations page of the Company\u2019s website at\u00a0Events & Presentations<\/u><\/a>. The webcast will be archived and available on Standard BioTool\u2019s Investor Relations page at\u00a0investors.standardbio.com<\/u><\/a>.<\/p>\n

\n About Standard BioTools Inc.<\/strong>\n <\/p>\n

Standard BioTools Inc. (Nasdaq:LAB), previously known as Fluidigm Corporation, is driven by a bold purpose \u2013\u202fUnleashing<\/em> tools to accelerate breakthroughs in human health.<\/em>\u202fStandard BioTools has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, the company provides reliable and repeatable insights in health and disease using its proprietary mass cytometry and microfluidics technologies, which help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. Learn more at www.standardbio.com or connect with us on Twitter\u00ae<\/a>, Facebook\u00ae<\/a>, LinkedIn<\/a>, and YouTube\u2122<\/a>. Standard BioTools, the Standard BioTools logo, Fluidigm, the Fluidigm logo, and \u201cUnleashing tools to accelerate breakthroughs in human health\u201d are trademarks and\/or registered trademarks of\u202fStandard BioTools Inc.\u202for its affiliates in\u202fthe United States\u202fand\/or other countries. All other trademarks are the sole property of their respective owners. Standard BioTools\u202fproducts are provided for\u202fResearch Use Only<\/strong>. Not for use in diagnostic procedures.<\/p>\n

\n Available Information<\/strong>\n <\/p>\n

Standard BioTools\u00a0uses its website (standardbio.com<\/a>), investor site (investors.standardbio.com<\/a>), corporate Twitter account (@Standard_BioT<\/a>), Facebook page (facebook.com\/StandardBioT),<\/a> and LinkedIn page (linkedin.com\/company\/standard-biotools<\/a>) as channels of distribution of information about its products, its planned financial and other announcements, its attendance at upcoming investor and industry conferences, and other matters. Such information may be deemed material information, and\u00a0Standard BioTools\u00a0may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Standard BioTools\u2019 website and its social media accounts in addition to following its press releases,\u00a0SEC\u00a0filings, public conference calls, and webcasts.<\/p>\n

\n Investors:<\/strong>\n <\/p>\n

Scott R. Greenstone, CFA
ir@standardbio.com<\/a>\u00a0<\/p>\n

Peter DeNardo
415 389 6400
ir@standardbio.com<\/a><\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SOUTH SAN FRANCISCO, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose \u2013\u202fUnleashing tools to accelerate breakthroughs in human health \u2013 today announced that it will report fourth quarter and full year 2022 financial results on\u00a0Tuesday, February 14, 2023, after the close of the market. The Company\u2019s management will host a conference call and webcast at\u00a02:00 p.m. PT, 5:00 p.m. ET, on February 14, 2023, to discuss fourth quarter and full year 2022 financial results and operational progress. A press release outlining the financial results will be publicly distributed before the call. Individuals interested in listening to the conference call may do so by dialing: US domestic callers: (888) 346-3970Outside US callers: (412) … <\/p>\n

Continue reading “Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-727191","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nStandard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose \u2013\u202fUnleashing tools to accelerate breakthroughs in human health \u2013 today announced that it will report fourth quarter and full year 2022 financial results on\u00a0Tuesday, February 14, 2023, after the close of the market. The Company\u2019s management will host a conference call and webcast at\u00a02:00 p.m. PT, 5:00 p.m. ET, on February 14, 2023, to discuss fourth quarter and full year 2022 financial results and operational progress. A press release outlining the financial results will be publicly distributed before the call. Individuals interested in listening to the conference call may do so by dialing: US domestic callers: (888) 346-3970Outside US callers: (412) … Continue reading "Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-31T13:48:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTExOCM1MzgxNDgwIzIwMDM4MTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results\",\"datePublished\":\"2023-01-31T13:48:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\\\/\"},\"wordCount\":486,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczOTExOCM1MzgxNDgwIzIwMDM4MTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\\\/\",\"name\":\"Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczOTExOCM1MzgxNDgwIzIwMDM4MTg=\",\"datePublished\":\"2023-01-31T13:48:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczOTExOCM1MzgxNDgwIzIwMDM4MTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczOTExOCM1MzgxNDgwIzIwMDM4MTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\/","og_locale":"en_US","og_type":"article","og_title":"Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose \u2013\u202fUnleashing tools to accelerate breakthroughs in human health \u2013 today announced that it will report fourth quarter and full year 2022 financial results on\u00a0Tuesday, February 14, 2023, after the close of the market. The Company\u2019s management will host a conference call and webcast at\u00a02:00 p.m. PT, 5:00 p.m. ET, on February 14, 2023, to discuss fourth quarter and full year 2022 financial results and operational progress. A press release outlining the financial results will be publicly distributed before the call. Individuals interested in listening to the conference call may do so by dialing: US domestic callers: (888) 346-3970Outside US callers: (412) … Continue reading \"Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\/","og_site_name":"Market Newsdesk","article_published_time":"2023-01-31T13:48:36+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTExOCM1MzgxNDgwIzIwMDM4MTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results","datePublished":"2023-01-31T13:48:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\/"},"wordCount":486,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTExOCM1MzgxNDgwIzIwMDM4MTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\/","name":"Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTExOCM1MzgxNDgwIzIwMDM4MTg=","datePublished":"2023-01-31T13:48:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTExOCM1MzgxNDgwIzIwMDM4MTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTExOCM1MzgxNDgwIzIwMDM4MTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/standard-biotools-announces-conference-call-and-webcast-for-fourth-quarter-and-full-year-2022-financial-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2022 Financial Results"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/727191","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=727191"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/727191\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=727191"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=727191"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=727191"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}